Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias. (2022)

First Author: Cantilena S

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ctm2.933

PubMed Identifier: 35730653

Publication URI: http://europepmc.org/abstract/MED/35730653

Type: Journal Article/Review

Volume: 12

Parent Publication: Clinical and translational medicine

Issue: 6

ISSN: 2001-1326